These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3260379

  • 1. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Pileblad E, Carlsson A.
    Pharmacol Toxicol; 1988 Apr; 62(4):213-22. PubMed ID: 3260379
    [Abstract] [Full Text] [Related]

  • 2. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE.
    Life Sci; 1988 Apr; 42(3):263-71. PubMed ID: 3121972
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW, Robertson DW, Hemrick-Luecke SK.
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [Abstract] [Full Text] [Related]

  • 6. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum.
    Pileblad E, Fornstedt B, Clark D, Carlsson A.
    J Pharm Pharmacol; 1985 Oct; 37(10):707-11. PubMed ID: 2416901
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse.
    Hallman H, Lange J, Olson L, Strömberg I, Jonsson G.
    J Neurochem; 1985 Jan; 44(1):117-27. PubMed ID: 3880581
    [Abstract] [Full Text] [Related]

  • 8. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 9. Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
    Reinhard JF, Daniels AJ, Viveros OH.
    Neurosci Lett; 1988 Aug 01; 90(3):349-53. PubMed ID: 3262206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice.
    Araki T, Kumagai T, Matsubara M, Ido T, Imai Y, Itoyama Y.
    Metab Brain Dis; 2000 Sep 01; 15(3):193-201. PubMed ID: 11206588
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches.
    Hara K, Tohyama I, Kimura H, Fukuda H, Nakamura S, Kameyama M.
    Brain Res; 1987 May 05; 410(2):371-4. PubMed ID: 3297254
    [Abstract] [Full Text] [Related]

  • 14. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice.
    Sundström E, Strömberg I, Tsutsumi T, Olson L, Jonsson G.
    Brain Res; 1987 Mar 03; 405(1):26-38. PubMed ID: 2882814
    [Abstract] [Full Text] [Related]

  • 15. Neurochemical investigations in vitro with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in preparations of rat brain.
    Markstein R, Lahaye D.
    Eur J Pharmacol; 1984 Nov 13; 106(2):301-11. PubMed ID: 6335691
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents.
    Fuller RW, Steranka LR.
    Life Sci; 1985 Jan 21; 36(3):243-7. PubMed ID: 3871244
    [Abstract] [Full Text] [Related]

  • 18. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW, Hemrick-Luecke SK, Perry KW.
    J Pharmacol Exp Ther; 1988 Nov 21; 247(2):531-5. PubMed ID: 3141609
    [Abstract] [Full Text] [Related]

  • 19. The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors.
    Bradbury AJ, Costall B, Jenner PG, Kelly ME, Marsden CD, Naylor RJ.
    Neuropharmacology; 1986 Aug 21; 25(8):897-904. PubMed ID: 3022182
    [Abstract] [Full Text] [Related]

  • 20. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
    Hemrick-Luecke SK, Robertson DW, Krushinski JH, Fuller RW.
    Life Sci; 1992 Aug 21; 50(8):573-82. PubMed ID: 1736028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.